[HTML][HTML] Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells
A Mansouri, LD Ridgway, AL Korapati, Q Zhang… - Journal of Biological …, 2003 - ASBMB
The efficacy of cisplatin in cancer chemotherapy is limited by the development of resistance.
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
A Mansouri, LD Ridgway, AL Korapati… - The Journal of …, 2003 - europepmc.org
The efficacy of cisplatin in cancer chemotherapy is limited by the development of resistance.
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Although the molecular mechanisms involved in chemoresistance are poorly understood …
[引用][C] Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells
A Mansouri, LD Ridgway, AL Korapati… - Journal of Biological …, 2003 - cir.nii.ac.jp
Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas
Ligand Induction and Cell Death in Ovarian Carcinoma Cells | CiNii Research CiNii 国立情報学 …
Ligand Induction and Cell Death in Ovarian Carcinoma Cells | CiNii Research CiNii 国立情報学 …
[PDF][PDF] Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells
A Mansouri, LD Ridgway, AL Korapati, Q Zhang, L Tian… - 2003 - researchgate.net
The efficacy of cisplatin in cancer chemotherapy is limited by the development of resistance.
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells
A Mansouri, LD Ridgway… - Journal of …, 2003 - mdanderson.elsevierpure.com
The efficacy of cisplatin in cancer chemotherapy is limited by the development of resistance.
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Although the molecular mechanisms involved in chemoresistance are poorly understood …
[HTML][HTML] Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells
A Mansouri, LD Ridgway, AL Korapati, Q Zhang… - Journal of Biological …, 2003 - Elsevier
The efficacy of cisplatin in cancer chemotherapy is limited by the development of resistance.
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells
A Mansouri, LD Ridgway, AL Korapati… - Journal of …, 2003 - ohsu.elsevierpure.com
The efficacy of cisplatin in cancer chemotherapy is limited by the development of resistance.
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells
A Mansouri, LD Ridgway… - The Journal of …, 2003 - pubmed.ncbi.nlm.nih.gov
The efficacy of cisplatin in cancer chemotherapy is limited by the development of resistance.
Although the molecular mechanisms involved in chemoresistance are poorly understood …
Although the molecular mechanisms involved in chemoresistance are poorly understood …